Predictive Oncology Form 3 shows director with no beneficial holdings
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Predictive Oncology Inc. (POAI) filed a Form 3 for a director, the initial statement of beneficial ownership under Section 16. The filing states no securities are beneficially owned as of the event date 10/07/2025. The submission includes an Exhibit 24.1 Power of Attorney, and was signed by Josh Blacher, Attorney-in-Fact. This is an administrative disclosure and does not reflect a transaction.
Positive
- None.
Negative
- None.
FAQ
What did Predictive Oncology (POAI) file?
A Form 3, which is the initial statement of beneficial ownership for insiders under Section 16.
Whose relationship to POAI is disclosed in the Form 3?
The person is identified as a Director of Predictive Oncology Inc.
Does the POAI director own any company securities?
The filing states No securities are beneficially owned.
What is the event date on the Form 3?
The event date is 10/07/2025.
How was the Form 3 signed?
It was signed by /s/ Josh Blacher, Attorney-in-Fact.
What additional document was included with the filing?
Exhibit 24.1 Power of Attorney was filed with the Form 3.
Is this Form 3 filed by one or multiple reporting persons?
It is indicated as Form filed by One Reporting Person.